Shail Patel
About Shail Patel
Shail Patel is the Associate Director of Enterprise Strategy and Analytics: WW Oncology at Bristol Myers Squibb, with a diverse background in healthcare, commerce, and innovative technologies.
Current Role at Bristol Myers Squibb
Shail Patel currently serves as the Associate Director of Enterprise Strategy and Analytics: WW Oncology at Bristol Myers Squibb. Starting in January 2020, Shail is responsible for leading strategic initiatives and analytics in the worldwide oncology division. His role involves using data-driven insights to inform business decisions and support the company's oncology portfolio.
Previous Experience at Regeneron Pharmaceuticals
Prior to joining Bristol Myers Squibb, Shail Patel worked as Senior Manager of Commercial Forecasting and Analytics: Oncology at Regeneron Pharmaceuticals, Inc. He held this role from 2019 to 2020 in the Greater New York City Area. His responsibilities included forecasting market trends, analyzing commercial data, and contributing to the strategic planning of oncology products.
Career at Eli Lilly and Company
Shail Patel has a substantial history with Eli Lilly and Company, where he held multiple roles in the field of oncology from 2013 to 2019. He started as a Visiting Scientist Fellow in Global Public Policy from 2013 to 2014, then transitioned to the Data Sciences and Solutions: Oncology team from 2014 to 2017. He later worked in Forecasting and Market Analytics: Oncology from 2017 to 2019. Across these roles, Shail utilized data science and market analytics to support the company’s oncology initiatives.
Pharmacist Role at Walmart
In addition to his roles in the pharmaceutical industry, Shail Patel served as a Pharmacist at Walmart from 2013 to 2020 in Indianapolis, Indiana. Over these seven years, he gained experience in the retail healthcare setting, providing valuable insights from both a commercial and clinical perspective.
Educational Background
Shail Patel holds a Doctor of Pharmacy (PharmD) degree from the University of New England. This advanced education provided him with a robust foundation in pharmacy practices, which he has leveraged throughout his diverse career in both healthcare and the pharmaceutical industry.